Amin MB, Smith SC, Agaimy A, et al
Amin MB, Smith SC, Agaimy A, et al. hemoglobinopathies, and if positive, SMARCB1/INI1 loss should be confirmed by immunohistochemistry. The majority of patients with RMC are diagnosed with metastatic disease. Upfront radical nephrectomy should be considered in patients with good performance status and low metastatic burden or after response to systemic therapy. Currently, cytotoxic, platinum-based… Read More: Amin MB, Smith SC, Agaimy A, et al »